Injectable Influenza Vaccine
Closed Pre-Solicitation Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- SPE2DP26R0003
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
Defense Logistics Agency Troop Support intends to solicit an indefinite-quantity contract for the supply of injectable influenza vaccine for the 2027-2028 flu season, with a response deadline of September 7, 2026. Approximately 1.5 million doses are required in prefilled-syringe presentation; quantities may increase or decrease pending final Service requirements. The guaranteed minimum will be 75 percent of the annual estimate, and the contract maximum will be capped at 150 percent of the annual estimate.
The vaccine must be FDA-approved for four age categories: 65 years and older, 18 years and older, 3 years and older, and 6 months to 35 months (pediatric). The successful contractor must hold FDA approval, and the vaccine must be CDC Advisory Committee on Immunization Practices (ACIP) recommended. The formula for the 2027-2028 season will be determined by the FDA Vaccines and Related Biological Products Advisory Committee. All deliveries shall be made to Defense Depot New Cumberland, Pennsylvania. The preferred delivery schedule requires 40 percent by August 12, 2027; 25 percent by August 26, 2027; 25 percent by September 9, 2027; and the residual 10 percent by September 23, 2027, though alternative schedules may be considered. National Stock Numbers will be established at award. The solicitation will be posted to DIBBS and SAM.gov. Questions should be directed to Rosbert Jones at 445-737-1254 or Rosbert.Jones@dla.mil.
Notice text
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2027-2028 flu season. Approximately 1.5 million doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for the following age categories: for immunizing individuals 65 years and older, for immunizing individuals 18 years and older, for immunizing individuals 3 years and older, and for immunizing 6 months to 35 months (pediatric group).
The formula for the 2027-2028 season shall be determined by the U.S. Food & Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval, and the vaccine must be U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. National Stock Numbers shall be established at the time of award.
An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.
All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the requirement by August 12, 2027, 25% by August 26, 2027, 25% by September 9, 2027, and the residual 10% by September 23, 2027. This delivery schedule is the preferred delivery schedule. Other delivery schedules may be considered.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (445-737-1254) (Rosbert.Jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is October of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Injectable Influenza Vaccine 2027 | Pre-Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity